Ko Hyun Lee, Jung Jiyun, Lee Jangwook, Lim Jeong-Hoon, Im Dha Woon, Kim Yong Chul, Paek Jin Hyuk, Park Woo Yeong, Kim Kyeong Min, Lee Soyoung, Lee Sung Woo, Shin Sung Joon, Kim Dong Ki, Han Seung Seok, Baek Chung Hee, Kim Hyosang, Park Jae Yoon, Ban Tae Hyun, Kim Kipyo
Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University, Gyeonggi-Do, Republic of Korea.
Clinical Trial Center, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.
Front Med (Lausanne). 2023 Mar 28;10:1162381. doi: 10.3389/fmed.2023.1162381. eCollection 2023.
Patients with acute kidney injury (AKI) receiving renal replacement therapy constitute the subgroup of AKI with the highest risk of mortality. Despite recent promising findings on the neutrophil-to-lymphocyte ratio (NLR) in AKI, studies have not yet addressed the clinical implication of the NLR in this population. Therefore, we aimed to examine the prognostic value of NLR in critically ill patients requiring continuous renal replacement therapy (CRRT), especially focusing on temporal changes in NLR.
We enrolled 1,494 patients with AKI who received CRRT in five university hospitals in Korea between 2006 and 2021. NLR fold changes were calculated as the NLR on each day divided by the NLR value on the first day. We performed a multivariable Cox proportional hazard analysis to assess the association between the NLR fold change and 30-day mortality.
The NLR on day 1 did not differ between survivors and non-survivors; however, the NLR fold change on day 5 was significantly different. The highest quartile of NLR fold change during the first 5 days after CRRT initiation showed a significantly increased risk of death (hazard ratio [HR], 1.65; 95% confidence intervals (CI), 1.27-2.15) compared to the lowest quartile. NLR fold change as a continuous variable was an independent predictor of 30-day mortality (HR, 1.14; 95% CI, 1.05-1.23).
In this study, we demonstrated an independent association between changes in NLR and mortality during the initial phase of CRRT in AKI patients receiving CRRT. Our findings provide evidence for the predictive role of changes in the NLR in this high-risk subgroup of AKI.
接受肾脏替代治疗的急性肾损伤(AKI)患者是AKI中死亡风险最高的亚组。尽管近期关于AKI中性粒细胞与淋巴细胞比值(NLR)有一些有前景的研究结果,但尚未有研究探讨NLR在该人群中的临床意义。因此,我们旨在研究NLR在需要持续肾脏替代治疗(CRRT)的危重症患者中的预后价值,尤其关注NLR的时间变化。
我们纳入了2006年至2021年期间在韩国五家大学医院接受CRRT的1494例AKI患者。NLR变化倍数的计算方法为每天的NLR除以第一天的NLR值。我们进行了多变量Cox比例风险分析,以评估NLR变化倍数与30天死亡率之间的关联。
幸存者和非幸存者第1天的NLR无差异;然而,第5天的NLR变化倍数有显著差异。CRRT开始后前5天NLR变化倍数的最高四分位数与最低四分位数相比,死亡风险显著增加(风险比[HR],1.65;95%置信区间[CI],1.27 - 2.15)。NLR变化倍数作为连续变量是30天死亡率的独立预测因素(HR,1.14;95% CI,1.05 - 1.23)。
在本研究中,我们证明了接受CRRT的AKI患者在CRRT初始阶段NLR变化与死亡率之间存在独立关联。我们的研究结果为NLR变化在这一AKI高风险亚组中的预测作用提供了证据。